|
阿莫西林
|
L352648-50mg
|
Moligand™, ≥95% |
26889-93-0 |
50mg
|
¥ 1899.9
|
现货 |
|
0 |
阿拉丁 |
|
碘化锂
|
L291068-2g
|
超干级, ≥99% metals basis |
10377-51-2 |
2g
|
¥ 199.9
|
现货 |
|
0 |
阿拉丁 |
|
犬尿酸-d5
|
K331381-1mg
|
≥98%,≥98atom%D |
350820-13-2 |
1mg
|
¥ 1809.9
|
现货 |
|
0 |
阿拉丁 |
|
3,3'-亚氨基二丙腈
|
I419708-100ml
|
≥98% |
111-94-4 |
100ml
|
¥ 1139.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-氟苯基环丙基甲酮
|
C590143-10g
|
≥97% |
772-31-6 |
10g
|
¥ 709.9
|
现货 |
|
0 |
阿拉丁 |
|
N-甲基二丁胺
|
I169712-100g
|
≥98% |
3405-45-6 |
100g
|
¥ 6493.9
|
现货 |
|
0 |
阿拉丁 |
|
咪唑并[1,2-a]吡啶-6-甲醛
|
I166172-250mg
|
≥97% |
116355-16-9 |
250mg
|
¥ 159.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三氟乙酸六氟异丙酯
|
H346459-5g
|
≥98% |
42031-15-2 |
5g
|
¥ 359.9
|
现货 |
|
0 |
阿拉丁 |
|
三氟乙酸六氟异丙酯
|
H346459-100g
|
≥98% |
42031-15-2 |
100g
|
¥ 3999.9
|
现货 |
|
0 |
阿拉丁 |
|
八水合二氯氧化铪(IV)
|
H283508-5g
|
≥98% metals basis, excluding Zr,Zr <1.5% |
14456-34-9 |
5g
|
¥ 229.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
四溴金酸氢盐(III)水合物
|
H283231-100mg
|
≥99.9% metals basis |
17083-68-0 |
100mg
|
¥ 899.9
|
现货 |
|
0 |
阿拉丁 |
|
AGS67E (anti-CD37)
|
Ab209859-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
N/A |
5mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
Tixagevimab (anti-Spike RBD)
|
Ab209842-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2420564-02-7 |
5mg
|
¥ 6669.9
|
现货 |
|
0 |
阿拉丁 |
|
Oxford Bio patent anti-Matriptase (anti-Matriptase)
|
Ab209782-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
N/A |
5mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
Regeneron patent anti-ANGPTL8 (anti-ANGPTL8)
|
Ab209779-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
N/A |
5mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
Diridavumab (anti-HA)
|
Ab191961-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1393659-46-5 |
5mg
|
¥ 6499.9
|
现货 |
|
0 |
阿拉丁 |
|
SAIT-301 (anti-c-Met)
|
Ab191924-5mg
|
无动物源, 无载体, 重组, ExactAb™, 低内毒素, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
N/A |
5mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
IMA-026 (anti-IL-13)
|
Ab190158-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1038541-65-9 |
5mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
Sirtratumab vedotin (anti-SLITRK6)
|
Ab183326-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
1824663-83-3 |
5mg
|
¥ 18879.9
|
现货 |
|
0 |
阿拉丁 |
|
Acasunlimab (anti-4-1BB&PD-L1)
|
Ab182989-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
2253937-12-9 |
5mg
|
¥ 17799.9
|
现货 |
|
0 |
阿拉丁 |
|
Inezetamab (anti-CD40&MSLN)
|
Ab182966-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
2568264-76-4 |
5mg
|
¥ 15199.9
|
现货 |
|
0 |
阿拉丁 |
|
1H-吡咯-2-羧酰胺
|
H184609-250mg
|
≥97% |
4551-72-8 |
250mg
|
¥ 269.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3(2H)-异噻唑酮
|
H178685-25g
|
≥98% |
1003-07-2 |
25g
|
¥ 2249.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
羟基红花黄色素A
|
H117996-5mg
|
分析标准品, ≥98% |
78281-02-4 |
5mg
|
¥ 199.9
|
现货 |
|
0 |
阿拉丁 |